WMUK’s response to the NHS 10-Year Health Plan consultation, focusing on the needs of Waldenstrom’s macroglobulinaemia (WM) patients. Key proposals include improving specialist care access, providing disease-specific information, increasing investment in Clinical Nurse Specialists, leveraging technology for better data and patient management, and reforming drug approval processes for rare cancers. It highlights the importance of equitable, community-based care supported by integrated systems and early diagnosis initiatives.
